JP2001519382A - 高血糖症治療のためのチアゾリジンジオンの使用 - Google Patents
高血糖症治療のためのチアゾリジンジオンの使用Info
- Publication number
- JP2001519382A JP2001519382A JP2000515578A JP2000515578A JP2001519382A JP 2001519382 A JP2001519382 A JP 2001519382A JP 2000515578 A JP2000515578 A JP 2000515578A JP 2000515578 A JP2000515578 A JP 2000515578A JP 2001519382 A JP2001519382 A JP 2001519382A
- Authority
- JP
- Japan
- Prior art keywords
- hyperglycemia
- insulin sensitizer
- plasma glucose
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721693.1A GB9721693D0 (en) | 1997-10-13 | 1997-10-13 | Novel treatment |
| GB9721693.1 | 1997-10-13 | ||
| PCT/GB1998/003064 WO1999018943A1 (en) | 1997-10-13 | 1998-10-12 | Use of thiazolidinediones for the treatment of hyperglycaemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001519382A true JP2001519382A (ja) | 2001-10-23 |
Family
ID=10820482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515578A Pending JP2001519382A (ja) | 1997-10-13 | 1998-10-12 | 高血糖症治療のためのチアゾリジンジオンの使用 |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1023056A1 (sh) |
| JP (1) | JP2001519382A (sh) |
| KR (1) | KR20010024481A (sh) |
| CN (1) | CN1281359A (sh) |
| AP (1) | AP2000001787A0 (sh) |
| AU (1) | AU9547098A (sh) |
| BG (1) | BG104404A (sh) |
| BR (1) | BR9815219A (sh) |
| CA (1) | CA2306086A1 (sh) |
| CZ (1) | CZ20001297A3 (sh) |
| EA (1) | EA002659B1 (sh) |
| GB (1) | GB9721693D0 (sh) |
| HR (1) | HRP20000255A2 (sh) |
| HU (1) | HUP0003922A3 (sh) |
| ID (1) | ID24521A (sh) |
| IL (1) | IL135513A0 (sh) |
| NO (1) | NO20001898L (sh) |
| NZ (1) | NZ503862A (sh) |
| OA (1) | OA11683A (sh) |
| PL (1) | PL339813A1 (sh) |
| SK (1) | SK5312000A3 (sh) |
| TR (1) | TR200000958T2 (sh) |
| WO (1) | WO1999018943A1 (sh) |
| YU (1) | YU28800A (sh) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
-
1997
- 1997-10-13 GB GBGB9721693.1A patent/GB9721693D0/en not_active Ceased
-
1998
- 1998-10-12 PL PL98339813A patent/PL339813A1/xx unknown
- 1998-10-12 BR BR9815219-0A patent/BR9815219A/pt not_active Application Discontinuation
- 1998-10-12 WO PCT/GB1998/003064 patent/WO1999018943A1/en not_active Application Discontinuation
- 1998-10-12 OA OA1200000108A patent/OA11683A/en unknown
- 1998-10-12 EA EA200000419A patent/EA002659B1/ru not_active IP Right Cessation
- 1998-10-12 TR TR2000/00958T patent/TR200000958T2/xx unknown
- 1998-10-12 EP EP98949086A patent/EP1023056A1/en not_active Withdrawn
- 1998-10-12 CZ CZ20001297A patent/CZ20001297A3/cs unknown
- 1998-10-12 HU HU0003922A patent/HUP0003922A3/hu unknown
- 1998-10-12 NZ NZ503862A patent/NZ503862A/xx unknown
- 1998-10-12 AP APAP/P/2000/001787A patent/AP2000001787A0/en unknown
- 1998-10-12 ID IDW20000669A patent/ID24521A/id unknown
- 1998-10-12 CA CA002306086A patent/CA2306086A1/en not_active Abandoned
- 1998-10-12 JP JP2000515578A patent/JP2001519382A/ja active Pending
- 1998-10-12 CN CN98812083A patent/CN1281359A/zh active Pending
- 1998-10-12 AU AU95470/98A patent/AU9547098A/en not_active Abandoned
- 1998-10-12 SK SK531-2000A patent/SK5312000A3/sk unknown
- 1998-10-12 YU YU28800A patent/YU28800A/sh unknown
- 1998-10-12 KR KR1020007003934A patent/KR20010024481A/ko not_active Application Discontinuation
- 1998-10-12 IL IL13551398A patent/IL135513A0/xx unknown
-
2000
- 2000-04-12 NO NO20001898A patent/NO20001898L/no not_active Application Discontinuation
- 2000-05-02 HR HR20000255A patent/HRP20000255A2/hr not_active Application Discontinuation
- 2000-05-05 BG BG104404A patent/BG104404A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20000255A2 (en) | 2001-02-28 |
| TR200000958T2 (tr) | 2000-08-21 |
| WO1999018943A1 (en) | 1999-04-22 |
| ID24521A (id) | 2000-07-20 |
| CN1281359A (zh) | 2001-01-24 |
| BR9815219A (pt) | 2001-01-02 |
| CZ20001297A3 (cs) | 2001-08-15 |
| EA200000419A1 (ru) | 2000-10-30 |
| NZ503862A (en) | 2003-01-31 |
| PL339813A1 (en) | 2001-01-02 |
| SK5312000A3 (en) | 2000-09-12 |
| EA002659B1 (ru) | 2002-08-29 |
| YU28800A (sh) | 2003-02-28 |
| NO20001898D0 (no) | 2000-04-12 |
| OA11683A (en) | 2005-01-12 |
| NO20001898L (no) | 2000-06-09 |
| EP1023056A1 (en) | 2000-08-02 |
| CA2306086A1 (en) | 1999-04-22 |
| KR20010024481A (ko) | 2001-03-26 |
| GB9721693D0 (en) | 1997-12-10 |
| IL135513A0 (en) | 2001-05-20 |
| BG104404A (bg) | 2000-12-29 |
| AP2000001787A0 (en) | 2000-06-30 |
| HUP0003922A3 (en) | 2001-12-28 |
| HUP0003922A2 (hu) | 2001-10-28 |
| AU9547098A (en) | 1999-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100666591B1 (ko) | 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료 | |
| JP2001510159A (ja) | チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療 | |
| JP2005247865A (ja) | チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療 | |
| WO2005079792A1 (ja) | 重症糖尿病網膜症の予防又は治療剤 | |
| JP2001510160A (ja) | チアゾリジンジオン、インスリン分泌促進薬およびアルファグルコシダーゼ阻害剤を用いる糖尿病の治療 | |
| JP2001523271A (ja) | チアゾリジンジオンおよびアルファ−グルコシダーゼ阻害剤を用いる糖尿病の治療 | |
| JP2002529430A (ja) | ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ | |
| JP2001523270A (ja) | チアゾリジンジオンおよびスルホニルウレアを用いる糖尿病の治療 | |
| JP2001519382A (ja) | 高血糖症治療のためのチアゾリジンジオンの使用 | |
| JP2001519383A (ja) | 高血糖症治療のためのチアゾリジンジオンの使用 | |
| US20040192737A1 (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| US20010031776A1 (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| JPH11510508A (ja) | インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法 | |
| MXPA00003633A (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| MXPA00003634A (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| AU4586902A (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| AU4587002A (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| MXPA99012098A (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050315 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050920 |